Cabaletta Bio, Inc.
CABA
$2.75
$0.041.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.33% | 8.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.44% | 3.95% | |||
| Operating Income | -17.44% | -3.95% | |||
| Income Before Tax | -17.24% | -3.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.24% | -3.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.24% | -3.81% | |||
| EBIT | -17.44% | -3.95% | |||
| EBITDA | -17.50% | -4.01% | |||
| EPS Basic | 13.11% | 2.90% | |||
| Normalized Basic EPS | 13.14% | 2.88% | |||
| EPS Diluted | 13.11% | 2.90% | |||
| Normalized Diluted EPS | 13.14% | 2.88% | |||
| Average Basic Shares Outstanding | 34.93% | 6.90% | |||
| Average Diluted Shares Outstanding | 34.93% | 6.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||